Skip to main content
. 2008 Jul 29;254(4):861–867. doi: 10.1016/j.jtbi.2008.07.030

Table 2.

Percentage occupation of hydrogen bonding between inhibitor and specific residues of SAR-CoV enzyme

Residue Type %Occupation
SARS-LPV SARS-RTV
T26 OG1_HG1---O3_LPV 18.7
T26 LPV_N4_H47---OG1 22.8
T26 LPV_N4_H47---O 36.9
H41 RTV_N2_H5---NE2 1.7
Y118 OH_HH---O5_LPV 2.8
N119 LPV_N4_H47---OD1 3.3
C145 RTV_N2_H5---SG 56.3
C145 SG_HG---O3_RTV 4.4
E166 N_H---N1_RTV 29.9
Q189 NE2_HE21---O1_LPV 9.9
Q189 NE2_HE21---N1_RTV 11.6
Q189 NE2_HE21---S1_RTV 7.6
Q189 NE2_HE21---O2_RTV 1.3
  NODES